A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report, European Journal of Hospital Pharmacy

Portuguese study reported a greater incidence of adverse drug reactions with hydroxychloroquine vs remdesivir (n=149; total of 102 events; 47.5% vs 12.5%; p
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news